CPT code 37195 denotes an interventional endovascular procedure in which a thrombolytic medication is infused via an intravenous catheter into a cerebral blood vessel to dissolve a clot and address acute cerebral ischemia. This intervention is clinically important because timely thrombolysis can reduce infarct size, improve neurological outcomes, and influence acute stroke care pathways nationwide. Payers commonly relevant to coverage and reimbursement discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise overview of the clinical context and procedural intent for CPT code 37195, along with what to expect in benchmarks and policy review sections. The publication covers national-level reimbursement benchmarks where available, common billing and documentation considerations tied to endovascular thrombolytic infusion, and recent payer policy trends affecting coverage determinations. When source data elements are not present in the input, the report notes "Data not available in the input." The content is intended for billing managers, hospital administrators, and clinicians involved in acute stroke services who need a clear reference to the code's purpose, expected settings of care, and payer landscape.